Comparable stake leader
INTRACOASTAL CAPITAL, LLC
SEC ownership of Microbot Medical Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000883975.
Disclosed value leader
INTRACOASTAL CAPITAL, LLC
Comparable rows
50/50
Latest evidence
31 Mar 2026
- Public ticker
- MBOT on Nasdaq
- Parsed ownership sources
-
13D/G and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
INTRACOASTAL CAPITAL, LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
INTRACOASTAL CAPITAL, LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
31 Mar 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0000883975
- Issuer location
- Hingham, MA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Microbot Medical Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
INTRACOASTAL CAPITAL, LLC
Disclosed value leader
INTRACOASTAL CAPITAL, LLC
Comparable rows
50/50
Latest evidence
31 Mar 2026
13D/G
13F
Lead comparable stake: 8.2%
13D/G row: INTRACOASTAL CAPITAL, LLC
Showing 1-8 of 50 holder rows.
Quick read
INTRACOASTAL CAPITAL, LLC leads the comparable SEC ownership view at 8.2%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens INTRACOASTAL CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
INTRACOASTAL CAPITAL, LLC
8.2%
CVI Investments, Inc.
4.9%
VANGUARD GROUP INC
4.4%
VANGUARD CAPITAL MANAGEMENT LLC
4%
CIBC Bancorp USA Inc.
2.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| INTRACOASTAL CAPITAL, LLC |
13D/G
Mitchell P. Kopin
|
8.2%
|
$12,004,370
6,002,185 shares
|
+$12,004,370 | 15 Jan 2026 |
| CVI Investments, Inc. |
13D/G
|
4.9%
|
$4,780,994
1,824,807 shares
|
+$1,487,280 | 31 Mar 2025 |
| VANGUARD GROUP INC |
13D/G
The Vanguard Group
|
4.4%
|
$7,147,861
2,343,561 shares
|
+$893,415 | 30 Sep 2025 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
Company
|
4%
|
$7,011,955
2,909,525 shares
|
— | 31 Mar 2026 |
| CIBC Bancorp USA Inc. |
13F
Company
|
2.6%
|
$4,506,700
1,870,000 shares
|
— | 31 Mar 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
1.3%
|
$2,227,580
924,307 shares
|
— | 31 Mar 2026 |
| BlackRock, Inc. |
13F
Company
|
1.2%
|
$2,066,329
857,398 shares
|
— | 31 Mar 2026 |
| UBS Group AG |
13F
Company
|
1.1%
|
$1,968,837
816,945 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 26 Jul 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-12 of 12 reporting-owner rows connected to Microbot Medical Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
12
Largest Forms 3/4/5 holder
Harel Gadot
Net 12M change
$0
Latest report
01 Apr 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Harel Gadot | Chairman, President and CEO, Director | Mixed | 18 Feb 2026 | |||
| Eyal Morag | Chief Medical Officer | Mixed | 01 Aug 2023 | |||
| David J. Wilson | Director | Mixed | 01 Apr 2026 | |||
| Martin J. Madden | Director | Mixed | 01 Apr 2026 | |||
| Prattipati Laxminarain | Director | Mixed | 01 Apr 2026 | |||
| Aileen Ptucha Stockburger | Director | Mixed | 01 Apr 2026 | |||
| Tal Baruch Wenderow | Director | Mixed | 01 Apr 2026 | |||
| Simon Sharon | General Manager, CTO | Mixed | 18 Feb 2026 | |||
| Yoseph Bornstein | Director | Mixed | 02 Nov 2023 | |||
| Scott R. Burell | Director | Mixed | 01 Apr 2026 | |||
| Rachel Vaknin | Chief Financial Officer | Mixed | 18 Feb 2026 | |||
| Juan Diaz-Cartelle | Chief Medical Officer | Mixed | 18 Feb 2026 |
Recent insider transactions for Microbot Medical Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Aileen Ptucha Stockburger | MBOT | Stock Option (Right to Buy) | Award | 10,000 | 10,000 | 01 Apr 2026 | Direct | |||
| Martin J. Madden | MBOT | Stock Option (Right to Buy) | Award | 10,000 | 10,000 | 01 Apr 2026 | Direct | |||
| Tal Baruch Wenderow | MBOT | Stock Option (Right to Buy) | Award | 10,000 | 10,000 | 01 Apr 2026 | Direct | |||
| David J. Wilson | MBOT | Stock Option (Right to Buy) | Award | 10,000 | 10,000 | 01 Apr 2026 | Direct | |||
| Scott R. Burell | MBOT | Stock Option (Right to Buy) | Award | 10,000 | 10,000 | 01 Apr 2026 | Direct | |||
| Prattipati Laxminarain | MBOT | Stock Option (Right to Buy) | Award | 10,000 | 10,000 | 01 Apr 2026 | Direct | |||
| Harel Gadot | MBOT | Stock Option (Right to Buy) | Award | 480,000 | 480,000 | 18 Feb 2026 | Direct | |||
| Juan Diaz-Cartelle | MBOT | Stock Option (Right to Buy) | Award | 105,000 | 105,000 | 18 Feb 2026 | Direct | |||
| Simon Sharon | MBOT | Stock Option (Right to Buy) | Award | 105,000 | 105,000 | 18 Feb 2026 | Direct | |||
| Rachel Vaknin | MBOT | Stock Option (Right to Buy) | Award | 105,000 | 105,000 | 18 Feb 2026 | Direct |
* marks a reported price that did not pass the local price check.